Back to top

Hikma Pharmaceuticals initiated with a Buy at Citi

Citi initiated coverage of Hikma Pharmaceuticals (HKMPF) with a Buy rating and 1,700 GBp price target The firm sees a “compelling” entry point at c...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Hikma Pharmaceuticals Plc (HKMPF)